Use of the Trypanosoma cruzi Recombinant Complement Regulatory Protein To Evaluate Therapeutic Efficacy following Treatment of Chronic Chagasic Patients

One of the greatest concerns in Chagas' disease is the absence of reliable methods for the evaluation of chemotherapy efficacy in treated patients. The tests available to evaluate cure after the specific treatment are the complement-mediated lysis (CoML) and flow cytometry tests, but they are not fe...

ver descrição completa

Detalhes bibliográficos

Publicado no:	J Clin Microbiol
Principais autores:	Meira, Wendell S. F., Galvão, Lúcia M. C., Gontijo, Eliane D., Machado-Coelho, George L. L., Norris, Karen A., Chiari, Egler
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 2004
Assuntos:	Parasitology
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC344465/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/14766840/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JCM.42.2.707-712.2004
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!